Company Filing History:
3 out of 24 
1 out of 1,011 
Years Active: 2014-2021
Title: Innovator Spotlight on Floris Jacob Bikker
Introduction
Floris Jacob Bikker is a notable inventor based in Gouda, Netherlands, whose contributions to the field of antimicrobial research have garnered attention. With a total of four patents to his name, Bikker is recognized for his innovative work that seeks to address critical medical challenges through advanced peptide technology.
Latest Patents
One of Bikker's most significant inventions is centered around antimicrobial peptides based on CMAP27. This invention focuses on derivatives of the CMAP27 peptide, which exhibit commendable antimicrobial activity while maintaining low haemolytic activity when compared to the wild-type CMAP27 peptide. These derivatives hold great promise for antibiotic therapy and can be integrated into bacteriocidal compositions. Furthermore, the application of CMAP27 and its derivatives as an adjuvant is also part of this innovative approach, indicating the versatility of Bikker's research.
Career Highlights
Throughout his career, Floris Jacob Bikker has worked with leading institutions, including Universiteit Utrecht Holding B.V. and the Netherlands Organization for Applied Scientific Research (TNO). His engagements in these organizations have allowed him to collaborate on impactful research and contribute to the scientific community in meaningful ways.
Collaborations
Bikker’s innovative journey has been enriched by collaborations with notable colleagues such as Albert Van Dijk and Rosalia Mars-Groenendijk. These partnerships have enabled a synergy of ideas and expertise, thereby enhancing the overall output of their research initiatives in antimicrobial peptide technologies.
Conclusion
Floris Jacob Bikker stands as a prominent figure in the field of innovation, particularly in the development of antimicrobial therapies. His patents reflect a commitment to advancing medical science through rigorous research and collaboration. As the demand for effective antimicrobial solutions continues to grow, Bikker’s contributions will undoubtedly play a crucial role in shaping the future of antibiotic therapy.